相关实验视频

Updated: Jun 8, 2025

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Published on: March 17, 2023

在小鼠中,β3上腺素受体激活缓解了PM_2.5诱导的肝脂沉积

Weijia Gu¹, Ruiqing Wang², Yanxi Chai²

¹School of Public Health, Zhejiang Chinese Medical University, Hangzhou, China; Zhejiang International Science and Technology Cooperation Base of Air Pollution and Health, Hangzhou, China.

The Science of the total environment

|November 4, 2024

概括

像CL-316,243这样的β-3上腺素受体 (β3-AR) 激动剂可以通过改善肝脂代谢来治疗诱导的细颗粒物物 (PM2.5) 代谢相关脂肪肝疾病 (MAFLD).

科学领域:

生物医学科学生物医学科学
药理学药理学是指药理学的学科.
毒理学毒理学毒理学

背景情况:

代谢相关的脂肪肝疾病 (MAFLD) 是一个日益严重的健康问题,通常由环境因素,如细颗粒物 (PM2.5) 等因素加剧.
增加肝细胞的能量消耗是PM2.5引起的MAFLD的潜在治疗策略.
贝塔3上腺素受体 (β3-AR) 激动剂在治疗MAFLD中的作用以前没有被探索过.

研究的目的:

调查选择性β3-AR激动剂CL-316,243在缓解PM2.5诱导的肝脂代谢障碍方面的治疗潜力.
为了阐明β3-AR激活的基础分子机制,以响应PM2.5暴露.

主要方法:

用CL-316,243治疗小鼠,以评估其对β3-AR表达和脂质资料的影响.
在暴露的最后一周内,小鼠被暴露在PM2.5中,随后接受了CL-316,243的治疗.
分析了肝脂沉积,酶活动 (SCD1,COX4) 和关键信号通路 (β3-AR/PKA/CREB/PPAR).

主要成果:

治疗CL-316,243提高了肝脏β3-AR表达的调节,降低了血清甘油三和自由脂肪酸.
暴露于PM2.5增加了肝脏甘油三和单不和脂肪酸,增加了SCD1活性,改变了TG合成和COX4活性.
通过增强SCD1活性,脂解和脂肪酸氧化,CL-316,243的使用缓解了PM2.5诱导的肝脂积累.

结论:

β3-AR激活有效地抵消PM2.5诱导的肝脂沉积和代谢功能障碍.
该β3-AR/PKA/CREB/PPAR信号通路对于调解CL-316,243对PM2.5诱导的MAFLD的保护作用至关重要.
β3-AR激动剂代表了一种有前途的治疗途径,用于管理与PM2.5暴露相关的MAFLD.

关键词:

微细颗粒物质的细颗粒物质的细颗粒物质脂质新陈代谢脂质新陈代谢在SCD1中,SCD1是SCD1.甘油三化物是一种三糖化物.作为β3-上腺受体的激动剂.

更多相关视频

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Published on: December 10, 2021

Assessing Whole-Body Lipid-Handling Capacity in Mice

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

相关概念视频

Adrenergic Receptors: β Subtype

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...